Navigation Links
RosetteSep Anti-Human IgE, 200 ul from StemCell Technologies, Inc.

ProductsRosetteSep Anti-Human IgE, 200 ul from StemCell Technologies, Inc.
Company StemCell Technologies, Inc.
Item RosetteSep Anti-Human IgE, 200 ul
Price 
Description This depletion cocktail is tailored to deplete IgE-bearing (I.e. basophils and mast cells) from whole blood
Info StemCell Technologies, Inc.StemCell Technologies, Inc.
570 West Seventh Avenue, Suite 400
Vancouver, BC, V5Z 1B3
Canada
Customer Service:
(604) 877-0713
(800) 667-0322

Fax Number:
(604) 877-0704
(800) 567-2899

Web Site: http://www.stemcell.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
2. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
3. Mouse Anti-Human Complement factor B Monoclonal Antibody, Unconjugated, Clone 9B6 from AntibodyShop A/S
4. Mouse Anti-Human Choriongonadotropin (hCG) Monoclonal Antibody, Unconjugated, Clone 5F10 from AntibodyShop A/S
5. Mouse Anti-Human Procollagen type I C-terminal propeptide (PICP) Monoclonal Antibody, Unconjugated from AntibodyShop A/S
6. Mouse Anti-Human Acetylcholinesterase, brain (AChE) Monoclonal Antibody, Unconjugated, Clone 12B4 from AntibodyShop A/S
7. Mouse Anti-Human a1-Antitrypsin (alpha-1 AT) Monoclonal Antibody, Unconjugated, Clone 4E5 from AntibodyShop A/S
8. Rabbit Anti-Human Sirtuin (silent mating type information regulation 2, S.cerevisiae, homolog) 7 (SIRT7) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
9. Goat Anti-Human RORgamma (S-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
10. Rabbit Anti-Human Rad51 Polyclonal Antibody, Unconjugated from Abcam
11. Mouse Anti-Human RAD51L3 Monoclonal Antibody, Unconjugated, Clone 1C8-3C11 from Novus Biologicals
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Calf Liver tRNA from Novagen
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products:
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In a...he bugs, they have natural enemies called bacterio...th every two days. , Still, bacteria and anothe...scovered in extreme environments such as deep-sea ...rt because they have a built-in defense system tha...
(Date:11/25/2009)... Over the course of a lifetime, the heart pumps so...n the order to do this, the muscle fibers of the h...oup headed by Dr. Wolfgang Rottbauer, vice chair o...versity Hospital (Chairman: Prof. Dr. H. A. Katus)... the stability of the smallest muscular unit, the ...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 1BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 2BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 3BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 4BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 5King Announces Commercial Availability of EMBEDA 28TM 29 57735 1King Announces Commercial Availability of EMBEDA 28TM 29 57735 2King Announces Commercial Availability of EMBEDA 28TM 29 57735 3King Announces Commercial Availability of EMBEDA 28TM 29 57735 4King Announces Commercial Availability of EMBEDA 28TM 29 57735 5King Announces Commercial Availability of EMBEDA 28TM 29 57735 6King Announces Commercial Availability of EMBEDA 28TM 29 57735 7King Announces Commercial Availability of EMBEDA 28TM 29 57735 8King Announces Commercial Availability of EMBEDA 28TM 29 57735 9King Announces Commercial Availability of EMBEDA 28TM 29 57735 10King Announces Commercial Availability of EMBEDA 28TM 29 57735 11Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies 14167 1Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies 14167 2
...chool biologists have figured out the fate of heal...ctious prion form in yeast: The protein converts t...nstant, good protein goes bad. , This quick-change...sterious molecular machinery behind prions, infect... as mad cow disease and scrapie in animals and, in...
...tion about the many things that could go wrong, re... Southeast Asian outbreak of avian influenza in hu... vaccine. , Using a computer model to simulate an ...e scientists have shown how a combination of strat...rals, quarantine and prevaccination -- even with a...
...e hunters and not the last ice age are the likely ...and other North American great mammals such as mam...University of Florida researcher. , Determining wh...f the American continent at the end of the last Ic...c sloths has puzzled scientists because both event...
Other Biology News:Prions rapidly 'remodel' good protein into bad, Brown study shows 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 3Study shows big game hunters, not climate change, killed off sloths 2Study shows big game hunters, not climate change, killed off sloths 3
(Date:11/24/2009)...lue Marble Energy Corp. announced today that the c... (OPDA) were recently awarded $2 million by Washin...rd (CERB) in a private/public partnership to const...finery in Lincoln County, WA. ,, "This invest...ur biorefinery and bring over 70 green jobs to Lin...
(Date:11/24/2009)...s been met for patients with advanced-stage, or... Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris...a global biopharmaceutical company focused on endo...ve efficacy data from a Phase 2 study with its tar...rly AN-152), in patients with advanced or recurren...
(Date:11/24/2009)...re-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: SHP...ny, today,announced that it has submitted a MAA to...lfa, the company,s enzyme replacement therapy in d...ease. This is the third marketing,application for ...revious,submissions in the United States and Canad...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Genomic Health, Inc. (Nasd...mic Health,s Executive Chairman, will present at t...e in New York City on Tuesday, December 1, 2009 at...equently archived webcast of the presentation, vis...h,s website at http://investor.genomichealth.com ...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2